China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 30.97
(1.44%)
CNY 30.97
(1.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.63 Billion | 2.75 Billion | 2.65 Billion | 2.51 Billion | 2.76 Billion | 2.38 Billion |
| Cost of Revenue | 1.31 Billion | 1.25 Billion | 1.14 Billion | 1.05 Billion | 976.57 Million | 863.29 Million |
| Gross Profit | 1.32 Billion | 1.5 Billion | 1.51 Billion | 1.45 Billion | 1.78 Billion | 1.52 Billion |
| Operating Expenses | 1.03 Billion | 985.59 Million | 1.04 Billion | 1.12 Billion | 1.24 Billion | 947.89 Million |
| Selling, General and Administrative Expenses | 587.87 Million | 738.31 Million | 829.72 Million | 925.11 Million | 1.02 Billion | 806.92 Million |
| Research and Development Expenses | 80.95 Million | 49.58 Million | 59.29 Million | 89.04 Million | 92.75 Million | 45.05 Million |
| Other Expenses | 179.88 Million | -179 Thousand | 10.77 Million | -3.32 Million | 5.92 Million | 7.7 Million |
| Cost and Expenses | 2.29 Billion | 2.23 Billion | 2.18 Billion | 2.18 Billion | 2.22 Billion | 1.81 Billion |
| Operating Income | 355.22 Million | 532.18 Million | 443.05 Million | 331.45 Million | 514.11 Million | 564.53 Million |
| Interest Expense | 800.53 Thousand | 622.91 Thousand | 10.52 Million | 21.45 Million | 30.76 Million | 23.97 Million |
| Income Tax Expense | 105.56 Million | 86.51 Million | 84.83 Million | 52.86 Million | 77.91 Million | 87.16 Million |
| Earnings before Tax | 353.71 Million | 532 Million | 443.11 Million | 328.13 Million | 520.03 Million | 572.24 Million |
| Net Income | 237.46 Million | 432.19 Million | 344.52 Million | 260.06 Million | 426.14 Million | 469.17 Million |
| Earnings Per Share Basic | 0.47 | 0.86 | 0.79 | 0.61 | 1.00 | 1.11 |
| Earnings Per Share Diluted | 0.47 | 0.86 | 0.79 | 0.61 | 1.00 | 1.11 |
| Weighted Average Shares Outstanding | 505.24 Million | 504.24 Million | 436.11 Million | 425.94 Million | 426.14 Million | 422.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 505.24 Million | 504.24 Million | 436.11 Million | 425.94 Million | 426.14 Million | 422.68 Million |
| Gross Margin | 0.50 | 0.55 | 0.57 | 0.58 | 0.65 | 0.64 |
| EBIT Margin | 0.18 | 0.25 | 0.24 | 0.17 | 0.23 | 0.28 |
| Profit Margin | 0.09 | 0.16 | 0.13 | 0.10 | 0.15 | 0.20 |
| EBITDA | 468.42 Million | 643.64 Million | 552.64 Million | 436.27 Million | 631.81 Million | 667.83 Million |
| Earnings Before Tax Margin | 0.13 | 0.19 | 0.17 | 0.13 | 0.19 | 0.24 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 349.37 Million | 443.27 Million | 448.45 Million | 457.2 Million | 2.63 Billion | 649.52 Million |
| Cost of Revenue | 119.68 Million | 163.33 Million | 144.45 Million | 172.23 Million | 1.31 Billion | 322.26 Million |
| Gross Profit | 229.68 Million | 279.94 Million | 303.99 Million | 284.97 Million | 1.32 Billion | 327.26 Million |
| Operating Expenses | 152.15 Million | 135.29 Million | 156.13 Million | 500.74 Million | 792.18 Million | 207 Million |
| Selling, General and Administrative Expenses | 202.88 Million | 124.15 Million | 141.99 Million | 152.48 Million | - | 269.35 Million |
| Research and Development Expenses | 17.05 Million | 10.28 Million | 19 Million | 18.52 Million | - | 10.33 Million |
| Other Expenses | -67.78 Million | -856.79 Thousand | 1.52 Million | -329.72 Million | -3.24 Million | -3.75 Million |
| Cost and Expenses | 271.84 Million | 298.62 Million | 300.59 Million | 672.97 Million | 2.1 Billion | 529.27 Million |
| Operating Income | 113.73 Million | 144.65 Million | 174.74 Million | -215.77 Million | 528.2 Million | 181.36 Million |
| Interest Expense | 20.59 Thousand | 85.86 Thousand | 18.61 Thousand | 43.58 Thousand | 455.59 Thousand | 130.38 Thousand |
| Income Tax Expense | 15.84 Million | 27.63 Million | 24.51 Million | 4.45 Million | 105.56 Million | 40.14 Million |
| Earnings before Tax | 112.57 Million | 191.57 Million | 176.27 Million | -221.49 Million | 353.71 Million | 181.61 Million |
| Net Income | 96.73 Million | 163.94 Million | 152.02 Million | -226.6 Million | 237.46 Million | 138.14 Million |
| Earnings Per Share Basic | 0.19 | 0.33 | 0.30 | -0.45 | - | 0.27 |
| Earnings Per Share Diluted | 0.19 | 0.33 | 0.30 | -0.45 | - | 0.27 |
| Weighted Average Shares Outstanding | 504.24 Million | 504.24 Million | 506.74 Million | 504.24 Million | 504.24 Million | 504.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 504.24 Million | 504.24 Million | 506.74 Million | 504.24 Million | 504.24 Million | 504.24 Million |
| Gross Margin | 0.66 | 0.63 | 0.68 | 0.62 | 0.50 | 0.50 |
| EBIT Margin | 0.32 | 0.39 | 0.35 | -0.41 | - | 0.24 |
| Profit Margin | 0.28 | 0.37 | 0.34 | -0.50 | 0.09 | 0.21 |
| EBITDA | 112.59 Million | 170.78 Million | 158.8 Million | -186.83 Million | - | 157.94 Million |
| Earnings Before Tax Margin | 0.33 | 0.33 | 0.39 | -0.47 | 0.20 | 0.28 |
688766
PGEL
ATO
ABSSF
1451
SNS